Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04680923Completed
Randomised, double-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by King Khalid University Hospital. Primary endpoint: Postoperative pain at 2 days. Started Dec 2020; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04680923.